ANTI-DIABETIC ACTIVITIES OF THE METHANOL LEAF EXTRACTS OF HYMENOCARDIA ACIDA (TUL.) IN ALLOXAN-INDUCED DIABETIC RATS

Authors

  • i Ihechiluru Ezeigbo
  • Isaac U Asuzu

Keywords:

Hymenocardia acida, Diabetes mellitus, Lipid profile, Glibenclamide, Alloxan monohydrate

Abstract

The effect of methanolic extract of Hymenocardia acida leaves on diabetes and associated lipidemia were investigated on experimentally-induced diabetic rats. The extract did not demonstrate any acutely toxic effect in rats within the dose range (250 mg/kg - 2000 mg/kg) employed in the study; hence it was well tolerated by the rats. In all experiments, the anti-diabetic effects were dose-dependent and comparable to that of glibenclamide (2 mg/kg) standard. At a dose of 500 mg/kg, lipid profile markers such as the serum total cholesterol (TC) levels, LDL-C, triglycerides and HDL-C were significantly lower (p <0.05) than those of both the treated and untreated controls.

Author Biography

i Ihechiluru Ezeigbo

Department of Veterinary Physiology, Biochemistry and Pharmacology, Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria

Downloads

Published

2011-11-08

How to Cite

Ezeigbo, i I., & Asuzu, I. U. (2011). ANTI-DIABETIC ACTIVITIES OF THE METHANOL LEAF EXTRACTS OF HYMENOCARDIA ACIDA (TUL.) IN ALLOXAN-INDUCED DIABETIC RATS. African Journal of Traditional, Complementary and Alternative Medicines, 9(2), 204–209. Retrieved from https://athmsi.org/journals/index.php/ajtcam/article/view/1439

Issue

Vol. 9 No. 2 (2012)

Section

Research Papers

License

Copyright: Creative Commons Attribution CC.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.